Reproducibility of histamine inhalation in asthmatics. 1986

A Bundgaard, and A Schmidt

The reproducibility of the changes in FEV, induced by inhalation of histamine, was studied in adult asthmatics. Histamine was inhaled from a Hudson nebulizer, delivering 0.3 ml/min, at tidal breathing through one minute. FEV was measured immediately before and two minutes after cessation of the inhalation. Identical concentrations of histamine were inhaled by the individual patient on every challenge. Reproducibility was studied on the same day, with one day inbetween the histamine challenges and with 12 weeks inbetween two challenges. When reproducibility during the same day was studied an average fall in FEV of 34% was found after the first inhalation and 34% decrease was found after the second challenge. When histamine challenge were done on two following days the fall in FEV was 25% on the first day and 28% on the second day. The average fall in FEV was 34% and 28% when reproducibility was studied with an interval of 12 weeks. No statistically significant difference was found between any of the compared challenges.

UI MeSH Term Description Entries
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

A Bundgaard, and A Schmidt
January 1986, European journal of respiratory diseases. Supplement,
A Bundgaard, and A Schmidt
January 1991, The Indian journal of chest diseases & allied sciences,
A Bundgaard, and A Schmidt
January 1983, Japanese journal of medicine,
A Bundgaard, and A Schmidt
January 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine,
A Bundgaard, and A Schmidt
January 1984, Respiration; international review of thoracic diseases,
A Bundgaard, and A Schmidt
August 1987, Casopis lekaru ceskych,
A Bundgaard, and A Schmidt
January 1974, The Medical clinics of North America,
A Bundgaard, and A Schmidt
May 1981, Drug and therapeutics bulletin,
A Bundgaard, and A Schmidt
July 1980, Clinical allergy,
A Bundgaard, and A Schmidt
June 1975, The Western journal of medicine,
Copied contents to your clipboard!